About C-type lectin domain family 18 member B
C-type lectin domain family 18 member B (CLEC18B) is a protein
from Homo sapiens identified by UniProt accession
Q6UXF7, 455 residues long.
MolForge cross-references it against 0 known binders and
15 disease associations.
Target properties
| Protein name | C-type lectin domain family 18 member B |
| UniProt accession | Q6UXF7 |
| Gene | CLEC18B |
| Organism | Homo sapiens |
| Length | 455 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (15)
Diseases linked to this target (Open Targets).
- neutrophil count · score 0.11
- glioblastoma multiforme · score 0.08
- diet measurement · score 0.07
- leukocyte count · score 0.06
- monocyte count · score 0.05
- risk-taking behaviour · score 0.05
- systolic blood pressure · score 0.04
- mood instability measurement · score 0.04
- neutrophil percentage of leukocytes · score 0.03
- Down syndrome · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UXF7-F1 | alphafold | PREDICTED | 78.97 | — |
Amino-acid sequence (455 residues)
MLHPETSPGR GHLLAVLLAL LGTTWAEVWP PQLQEQAPMA GALNRKESFL LLSLHNRLRS WVQPPAADMR RLDWSDSLAQ LAQARAALCG IPTPSLASGL WRTLQVGWNM QLLPAGLASF VEVVSLWFAE GQRYSHAAGE CARNATCTHY TQLVWATSSQ LGCGRHLCSA GQTAIEAFVC AYSPGGNWEV NGKTIIPYKK GAWCSLCTAS VSGCFKAWDH AGGLCEVPRN PCRMSCQNHG RLNISTCHCH CPPGYTGRYC QVRCSLQCVH GRFREEECSC VCDIGYGGAQ CATKVHFPFH TCDLRIDGDC FMVSSEADTY YRARMKCQRK GGVLAQIKSQ KVQDILAFYL GRLETTNEVI DSDFETRNFW IGLTYKTAKD SFRWATGEHQ AFTSFAFGQP DNHGLVWLSA AMGFGNCVEL QASAAFNWND QRCKTRNRYI CQFAQEHISR WGPGS
Explore C-type lectin domain family 18 member B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets